• About
  • APFL
  • Climate Bio™
  • News

AFINGEN’s advisers, Dr. Dominique Loqué & Dr. Henrik Scheller received 2014 R&D 100 Award

by Sandesh | Jan 21, 2022 | Uncategorized

Each year, R & D Magazine’s R&D 100 Awards are presented to the 100 most significant new technologies. Over the past 35 years, Berkeley Lab has received 95 R&D 100 awards. Tissue-Specific Cell-Wall Engineering for Biofuels and Biomaterials is a suite of...

AFINGEN received $1.72M research grant from DOE SBIR Fast-track program

by Sandesh | Jan 21, 2022 | Uncategorized

Source: https://science.osti.gov/sbir The SBIR and STTR programs are U.S. Government programs, intended to help certain small businesses conduct R&D. At DOE, funding takes the form of grants. Projects must have the potential for commercialization and meet...
Next Entries »

Recent Posts

  • AFINGEN was introduced in ABPDU partners map on DOE Bioenergy Technologies Office (BETO)’s article
  • AFINGEN was introduced in TechAccel Ag Biotech Market Map: Stunning growth in Ag Biotech Market investments
  • AFINGEN’s new patent-pending APFL technology was published on World Intellectual Property Organization (WIPO): WO2019148193
  • “AFINGEN” becomes a business trademark in International Class 41 and 45 under the United States Patent and Trademark Office (USPTO)
  • AFINGEN was introduced on TechAccel & AgFunder’s Ag Biotech Market Map: Startups Using Biology & Chemistry to Revolutionize Agriculture

Recent Comments

No comments to show.
Contact

Information



220 4th St, Oakland, CA 94607



(650) 420-5580


hello@afingen.tech

AFINGEN® is owned and operated by ASTALAKE BIOSYSTEMS, INC., as an agriculture technology brand to meet the natural resource demand in new sustainable manners.

© 2025 ASTALAKE BIOSYSTEMS INC. ALL RIGHTS RESERVED. | Privacy Policy